Phenotyping heterozygous carriers of juvenile neuronal ceroid lipofuscinosis with CLN3 mutations

被引:0
作者
Richard Bergholz
Alfried Kohlschütter
Angela Schulz
Waltraud Hubert
Klaus Rüther
机构
[1] Charité – Universitätsmedizin Berlin,Department of Ophthalmology
[2] University Medical Center Eppendorf,Children’s Hospital
[3] Sankt Gertrauden-Krankenhaus,Department of Ophthalmology
[4] Charité Augenklinik Campus Virchow-Klinikum,undefined
来源
Graefe's Archive for Clinical and Experimental Ophthalmology | 2015年 / 253卷
关键词
Neuronal ceroid lipofuscinosis; CLN3; Batten disease; Electroretinography; Optical coherence tomography;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1245 / 1250
页数:5
相关论文
共 44 条
[1]  
Schulz A(2013)NCL diseases - clinical perspectives Biochim Biophys Acta 1832 1801-6
[2]  
Kohlschütter A(2012)The juvenile Batten disease protein, CLN3, and its role in regulating anterograde and retrograde post-Golgi trafficking Clin Lipidol 7 79-91
[3]  
Mink J(1998)Aberrant phenylalanine metabolism in phenylketonuria heterozygotes J Inherit Metab Dis 21 365-72
[4]  
Simonati A(1990)Oral loading of homogentisic acid in controls and in obligate heterozygotes for hereditary tyrosinemia type I Am J Hum Genet 47 329-37
[5]  
Williams R(2001)Delayed dark-adaptation and lipofuscin accumulation in abcr+/− mice: implications for involvement of ABCR in age-related macular degeneration Invest Ophthalmol Vis Sci 42 1685-90
[6]  
Cotman SL(1986)The heterozygote advantage in phenylketonuria Am J Hum Genet 38 773-5
[7]  
Staropoli JF(1988)Electrophysiological findings of neuronal ceroid lipofuscinosis in heterozygotes Graefes Arch Clin Exp Ophthalmol 226 516-21
[8]  
Guldberg P(2009)Autofluorescence and infrared retinal imaging in patients and obligate carriers with neuronal ceroid lipofuscinosis Ophthalmic Genet 30 190-8
[9]  
Henriksen KF(2009)ISCEV Standard for full-field clinical electroretinography (2008 update) Doc Ophthalmol 118 69-77
[10]  
Lou HC(2012)ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition) Doc Ophthalmol 124 1-13